Suggestions
Rodrigo Palacios
Lead, Regulatory Technology Policy at Roche
Professional Background
Rodrigo Palacios has cultivated a robust professional career characterized by his leadership in regulatory technology and information systems within the pharmaceutical industry. Currently, he serves as the Lead for Regulatory Technology Policy at Roche, where he is pivotal in navigating the complex landscape of regulatory compliance and technological innovations. His profound knowledge and expertise in regulatory affairs have been honed over years of dedicated work across various renowned organizations in the life sciences sector.
Palacios's trajectory includes significant roles that have molded him into a key figure in the intersection of technology and regulatory compliance in pharmaceuticals. Before his current role at Roche, he made substantial impacts as the Global Head of Pharma Technical Regulatory Business Systems at Roche, where he streamlined processes and optimized technology solutions to enhance regulatory operations. His commitment to advancing regulatory technologies is further illustrated by his prior responsibility as the Co-chair of the Regulatory Information and Technology Expert Group (RITEG) at EFPIA, and as a member of the Information and Technology Workgroup at PhRMA. These positions enabled him to collaborate with industry leaders to establish best practices and innovative solutions in regulatory technology.
In addition, Palacios has a wealth of experience from his time at Genentech, where he began his journey as a Senior Software Engineer and progressed to Senior Systems Architect and IT Systems Lead for Regulatory Affairs. His technical prowess and analytical capabilities positioned him to architect systems that play a crucial role in regulatory compliance and data management. Further demonstrating his entrepreneurial spirit, Palacios founded Moberati, Inc., where he served as Principal, emphasizing his commitment to driving innovation and integration of regulatory affairs with advanced technology solutions.
Education and Achievements
Rodrigo Palacios is a strong advocate for continuous learning and growth, evidenced by his impressive educational background. He earned a Bachelor of Science in Computer Science from Tecnológico De Monterrey, a prestigious institution known for cultivating leaders in technology and innovation. His foundational knowledge in computer science has been pivotal in his ability to integrate complex technical systems within regulatory frameworks.
Further enhancing his qualifications, Palacios pursued a Master of Business Administration in Management at the University of California, Berkeley, Haas School of Business. This advanced education provided him with critical insights into management, strategy, and the operational aspects of running a successful business within the healthcare and pharmaceutical landscapes. His educational achievements equip him to not only navigate the technical aspects of regulatory affairs but also to lead teams and influence strategic decisions effectively.
Key Achievements
Throughout his esteemed career, Rodrigo Palacios has garnered numerous accolades that highlight his contributions to the pharmaceutical industry. His leadership in regulatory technology has been pivotal in fostering innovation and ensuring compliance in an increasingly digital world. At Roche, his innovative strategies in regulatory technology policy have set benchmarks that increase efficiency and reliability in the sector.
His previous roles, particularly as Global Head of Pharma Technical Regulatory Business Systems at Roche and Co-chair at RITEG, reflect a history of collaboration and leadership, influencing regulatory practices on a global scale. Palacios’s ability to synthesize complex regulatory requirements with advanced technological solutions has proven invaluable in streamlining operations and guiding transformative projects.
In recognition of his expertise and influence, his participation in high-level committees and workgroups has provided him with a platform to shape industry norms and foster partnerships that are fundamental in navigating regulatory landscapes effectively. His journey, marked by innovation and commitment, reflects not just his personal achievements but also his lasting impact on the regulatory technology landscape in the pharmaceutical industry.
